Delphi Ventures

Delphi Ventures was founded over 25 years ago as one of the first venture capital firms to focus on investing in life sciences companies.

Business Model:

Revenue: $16.7M

Employees: 2-10

Rankings

Detailed Delphi Ventures Information

Geographic Data

Delphi Ventures headquarters map

Address: 3000 Sand Hill Rd

City: Menlo Park

State: CA

Zip: 94025

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Delphi Ventures is a venture capital firm that has focused on investing in biotechnology and medical devices for over two decades. With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 110 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.

Contact Phone:
+16508549650

Contact Email:

Announced Date Company Transaction Money Raised
8/2005 Adiana Series D 23M
3/2012 Sequent Medical Series C 26M
11/2001 Locus Pharmaceuticals Series C 0
11/2000 Locus Pharmaceuticals Series B 0
8/2000 Ican Venture Round 4M
12/2007 Barosense Series C 11.2M
3/2011 Astute Medical Series B 13M
6/2013 ForSight VISION5 Series B 9.3M
3/2006 Breathe Technologies Series A 4M
5/2010 Breathe Technologies Series C 23M
8/2001 MicroVention Terumo Series C 12.5M
5/2010 Astute Medical Series B 26.5M
10/2005 PhotoThera Series B 19M
2/2011 EBR Systems Series D 5M
2/2009 Primaeva Medical Series C 6M
8/2000 Ican Venture Round 4M
5/2011 AEGEA Medical Series B 0
6/2004 Paracor Medical Series C 30.5M
6/2007 Paracor Medical Series D 44M
1/2001 Salmedix Series A -
4/2000 AmericasDoctor.com Venture Round 33.5M
1/2008 Aragon Surgical Series B 25M
7/2013 Karyopharm Therapeutics Series B 19M
9/2014 Ivantis Series B 25M
2/2000 Agiliti Series B 0
4/2015 EBR Systems Venture Round 20M
3/2008 Labcyte Series C 0
3/2021 Covalent Venture Round 0
8/2007 Vibrynt Series A 16M
5/2009 PhotoThera Series D 50M
11/2008 OncoMed Pharmaceuticals Series B 154M
4/2006 PhotoThera Series C 30.5M
9/2010 Relypsa Series B 70M
7/2012 PTC Therapeutics Private Equity Round 30M
5/2011 Cameron Health Series F 107M
8/2007 NeurAxon Series B 32M
8/2011 Relypsa Series B 70.1M
5/1999 Xenogen Corporation Series D 11M
11/2018 LeddarTech Convertible Note 0
4/2006 SynergEyes Series B 0
9/2008 Proteolix Series C 79M
7/2005 Ilypsa Series B 36M
4/2014 Sequent Medical Series D 20M
9/2010 NeurAxon Debt Financing 0
3/2021 APWine Seed Round 0
7/2012 Vifor Pharma Private Equity Round 0
11/2002 Alliance Medical Corporation Series E 7.3M
4/2000 Digineer Venture Round 20M
1/2004 PTC Therapeutics Series E 35M
1/2021 Armor Venture Round -
6/2011 PolyRemedy Series C 20M
8/2021 Apricot Finance Seed Round 0
7/2004 LipoSonix Series C 27M
6/2008 EBR Systems Series C 35M
4/2015 Cardeas Pharma Series B 37.5M
3/2021 Syndicate Seed Round 1M
12/2007 Alder Biopharmaceuticals Series C 40M
5/2006 Eledon Pharmaceuticals Series B 35M
1/2018 AEGEA Medical Series D 0
1/2008 Arbor Surgical Technologies Series C 0
11/2011 Pivot Medical Series C 32M
6/2010 Anulex Technologies Series E 18.3M
3/2000 GoToMyDoc Venture Round 25M
6/2009 VytronUS Series A 11M
6/2014 Senseonics Venture Round 0
10/1999 The Online Asset Exchange Series A 15.6M
9/1999 Alliance Medical Corporation Series A 8.5M
4/2004 NOVASYS MEDICAL Series C 25M
9/2000 Alliance Medical Corporation Series B 8M
6/2005 Cierra Funding Round 21M
3/2007 Phenomix Series C 55M
9/2001 PTC Therapeutics Series D 0
8/2012 Vifor Pharma Series C 0
1/2005 Aragon Surgical Series A -
6/2021 Pontem Network Venture Round 0
11/2005 PTC Therapeutics Private Equity Round 26.6M
12/2003 KAI Pharmaceuticals Series A 17M
5/2006 KAI Pharmaceuticals Series B 35M
6/2004 PTC Therapeutics Series E 0
5/2013 Karyopharm Therapeutics Series B 48.2M
1/2008 PixelOptics Series B 23.8M
9/2006 PixelOptics Series A 8.4M
10/2008 PixelOptics Series C 30M
12/2009 PTC Therapeutics Venture Round 50M
3/2013 PTC Therapeutics Private Equity Round 60M
1/2013 Ivantis Series B 27M
8/2007 VytronUS Series A 6.6M
2/2007 PTC Therapeutics Series F 10M
7/2006 Anulex Technologies Series C 20M
1/2022 Friktion Labs Venture Round 0
11/2007 Evalve Series D 0
3/2008 TriVascular Series A 65M
8/2009 Barosense Series D 27M
6/2012 Astute Medical Series C 40.4M
7/2010 Calithera Biosciences Series A 40M
6/2012 TriVascular Series D 60M
5/2000 Xenogen Corporation Series E 30.6M
2/2022 Jambo Seed Round 0
5/2022 Jambo Series A 0
11/2011 Calithera Biosciences Venture Round 4M
4/2023 Karate Combat Venture Round 0
2/2000 Accordant Health Services Venture Round 14M
6/2008 Cameron Health Series E 0
4/2014 ForSight VISION5 Equity 15M
1/2005 Alexza Pharmaceuticals Series D 0
1/2014 Ivantis Series B 14M
3/2008 Breathe Technologies Series B 15M
5/2004 Evalve Series C 0
5/2009 Anulex Technologies Series D 10.2M
8/2010 TriVascular Series C 60M
11/2009 TriVascular Series B 30M
4/2007 Acclarent Series C 35M
11/2013 TriVascular Series E 0
3/2021 XDEFI Wallet Seed Round 1.2M
5/2023 FastLane Seed Round 0
6/2022 Tatsumeeko Seed Round 0
1/2002 ActivBiotics Series A 17M
5/2003 TranS1 Series B 0
4/2007 Reliant Technologies Series E 15M
5/2008 Novasys Health Venture Round 49.5M
11/2003 Cameron Health Series B 29M
5/2008 Novasys Medical, Inc. Series D 49.5M
1/2006 Primaeva Medical Series A 1.3M
9/2021 RECUR Series A 0
7/2006 Cameron Health Series D 31M
4/2005 Phenomix Series B 20M
8/2010 NeuroVista Venture Round 16.5M
10/2007 Vital Therapies Series C 28.1M
6/2006 Proteolix Series B 45M
6/2002 Salmedix Series B 27.5M
8/2021 Chainflip Seed Round 0
1/2009 Acclarent Venture Round 26M
10/2007 Relypsa Series A 33M
7/2003 Refractec Series D 9M
4/2011 PixelOptics Series D 45M
4/2014 Sotera Wireless Venture Round 0
7/2008 ELENZA Series A 497k
10/2013 Calithera Biosciences Series D 35M
12/2006 Primaeva Medical Series B 7M
9/2012 Tandem Diabetes Care Series D 36.4M
12/2012 Calithera Biosciences Series C 2M
4/2003 Arbor Surgical Technologies Series A 10.8M
7/2014 EBR Systems Venture Round 18.7M
8/2000 The Online Asset Exchange Series B 25M
12/2008 ELENZA Series B 6M
3/2023 Jungle Seed Round 0
2/2011 ELENZA Series B 24M
8/2021 Fractional Seed Round 0
1/2001 Labcyte Series A -
7/2002 Barosense Series A 6.2M
1/2010 Tandem Diabetes Care Series C 53M
12/2004 Barosense Series B 6.2M
12/2009 EBR Systems Venture Round 15M
7/2010 BARRX Medical Series D 15M
7/2002 Labcyte Series B 22M
2/2009 SynergEyes Series C 0
3/2008 AEGEA Medical Series A 2.1M
9/2001 NOVASYS MEDICAL Series B 13M
1/2013 Labcyte Series D 0
7/2006 BARRX Medical Series C 27.8M
4/2012 Alder Biopharmaceuticals Series D 0
4/2013 Revance Therapeutics Series E 33M
5/2015 AEGEA Medical Series C 0
2/2007 Proacta Series B 35M
2/2013 Sotera Wireless Series D 0
3/2006 Reliant Technologies Series D 22M
5/2007 NeuroVista Series B 33.8M
10/2008 Lutonix Series B 20M
6/2013 ForSight Labs Series B 9.3M
6/2022 Tatsumeeko Seed Round 0
5/2022 Jambo Series A 0
2/2022 Jambo Seed Round 0
1/2022 Friktion Labs Venture Round 0
9/2021 RECUR Series A 0
8/2021 Apricot Finance Seed Round 0
8/2021 Fractional Seed Round 0
6/2021 Pontem Network Venture Round 0
3/2021 Covalent Venture Round 0
3/2021 XDEFI Wallet Seed Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research